| Literature DB >> 31703621 |
Elizaveta Gavrilova1, Elizaveta Anisimova1, Alsu Gabdelkhadieva2, Elena Nikitina1,2, Adel Vafina2, Dina Yarullina1, Mikhail Bogachev1,3, Airat Kayumov4.
Abstract
BACKGROUND: Raw milk, meat and plant materials are subjected to high risks of contamination by various pathogenic bacteria and thus their growth prevention is a great challenge in the food industry. Food fermentation by lactic acid bacteria (LAB) besides changing its organoleptic characteristics also helps to eliminate unfavorable microflora and represses growth of pathogens. To the date only few LABs has been reported to exhibit activity against bacteria embedded in the biofilms characterized by extreme resistance to antimicrobials, high exchange rate with resistance genes and represent high risk factor for foodborne disease development.Entities:
Keywords: Antagonism; Biofilms; Lactic acid bacteria; Lactobacillus; Milk fermentation
Year: 2019 PMID: 31703621 PMCID: PMC6839075 DOI: 10.1186/s12866-019-1618-0
Source DB: PubMed Journal: BMC Microbiol ISSN: 1471-2180 Impact factor: 3.605
Antimicrobial activity of LAB strains isolated from silage (agar drop diffusion test)
| LAB species | Strain | Growth inhibition, mm | ||||
|---|---|---|---|---|---|---|
| AG1 | 8.5 ± 2.1 | 10.0 ± 2.8* | 13.0 ± 2.8* | 5.5 ± 2.1 | 9.0 ± 1.4 | |
| AG8 | 8.5 ± 2.1 | 9.5 ± 0.7 | 13.0 ± 2.8* | 6.5 ± 0.7* | 9.5 ± 0.7* | |
| AG9 | 8.5 ± 2.1 | 8.5 ± 2.1 | 8.0 ± 2.8 | 6.0 ± 0.3 | 7.5 ± 2.1 | |
| AG10 | 8.0 ± 1.4 | 11.0 ± 1.4* | 11.0 ± 1.4* | 6.0 ± 1.4 | 9.5 ± 0.7* | |
| AG15 | 10.0 ± 0.2* | 11.5 ± 0.7* | 12.5 ± 3.5* | 6.5 ± 0.7* | 9.0 ± 0.2 | |
| AG16 | 9.0 ± 1.4 | 13.0 ± 0.2* | 12.5 ± 3.5* | 7.0 ± 0.2* | 9.5 ± 2.1* | |
| 8PA3 | 7.5 ± 1.6 | 7.9 ± 0.6 | 9.1 ± 0.4 | 5.0 ± 0.5 | 8.0 ± 1.3 | |
* denotes statistically significant difference with probiotic strain L. plantarum 8PA3 (p < 0.05)
Fig. 1Antimicrobial activity of novel LAB strains against planktonic and biofilm embedded forms of pathogenic bacteria. LAB suspensions in MRS broth without sorbic acid (107 CFU/ml) were added to 48-h old biofilms of pathogenic bacteria. After 24 h CFUs of bacteria were calculated on differential media. Data are shown as medians with IQR. Asterisks denote statistically significant difference with monocultures of pathogenic bacteria (p < 0.05)
Fig. 2Repression of pathogenic bacteria by newly isolated LAB strains in co-cultivation experiments. Suspensions of LAB and pathogenic bacteria (107 CFU/mL each) in MRS broth without sorbic acid were grown for 48-h and CFUs of bacteria were calculated on differential media. Data are shown as medians with IQR. Asterisks denote statistically significant difference with monocultures of pathogenic bacteria (p < 0.05)
The broth acidification rate by novel LAB strains isolated from silage growing in wells with 48-h old biofilms of pathogenic bacteria
| Glucose | Strains | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| ΔpH | 2% | 3.4 ± 0.35* | 3.2 ± 0.24* | 3.4 ± 0.31* | 3.6 ± 0.56* | 3.3 ± 0.23* | 3.2 ± 0.11* | 2.3 ± 0.15 | |
| 2.5 ± 0.55 | 2.6 ± 0.22* | 2.5 ± 0.54 | 2.5 ± 0.5 | 2.4 ± 0.39 | 3.1 ± 0.91* | 2.4 ± 0.51 | |||
| 3.1 ± 0.21* | 3.1 ± 0.14* | 3.1 ± 0.21* | 3.1 ± 0.23* | 3.1 ± 0.23* | 3.2 ± 0.25* | 2.8 ± 0.25 | |||
| 2.0 ± 0.11 | 2.0 ± 1.08 | 2.0 ± 1.10 | 2.0 ± 1.15 | 2.0 ± 1.15 | 1.8 ± 1.44 | 1.8 ± 1.11 | |||
| 3.3 ± 0.18* | 3.4 ± 0.23* | 3.2 ± 0.25* | 3.1 ± 0.06* | 3.1 ± 0.09 | 3.4 ± 0.50* | 2.9 ± 0.41 | |||
| 0.2% | 2.5 ± 0.34* | 2.0 ± 0.53* | 2.2 ± 0.46* | 1.8 ± 0.27* | 2.2 ± 0.38* | 2.2 ± 0.62* | 1.2 ± 0.25 | ||
| 0.8 ± 0.79 | 1.0 ± 0.76* | 0.2 ± 0.38 | 0.1 ± 0.88 | 1.0 ± 0.86* | 1.0 ± 0.88* | 0.7 ± 0.43 | |||
| 1.7 ± 0.64* | 1.6 ± 0.47* | 1.7 ± 0.52* | 1.7 ± 0.66* | 1.7 ± 0.64* | 1.6 ± 0.54* | 0.6 ± 0.30 | |||
| 0.5 ± 0.68 | 0.1 ± 0.50 | 0.4 ± 0.37 | 0.5 ± 0.64* | 0.6 ± 0.80* | 0.3 ± 0.56 | 0.2 ± 0.62 | |||
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| ΔTTA | 2% | 2.2 ± 0.63* | 1.5 ± 0.43* | 1.7 ± 0.65* | 2.3 ± 0.87* | 1.8 ± 0.57* | 1.3 ± 0.23* | 1.1 ± 0.01 | |
| 0.3 ± 0.12 | 0.3 ± 0.10 | 0.3 ± 0.09 | 0.3 ± 0.05 | 0.3 ± 0.07 | 0.6 ± 0.03* | 0.3 ± 0.04 | |||
| 1.1 ± 0.21* | 1.3 ± 0.18* | 1.5 ± 0.65* | 1.1 ± 0.21* | 1.1 ± 0.21* | 1.3 ± 0.34* | 0.5 ± 0.02 | |||
| 0.7 ± 0.20 | 0.5 ± 0.15 | 0.5 ± 0.08 | 0.6 ± 0.09 | 0.6 ± 0.06 | 0.6 ± 0.06 | 0.6 ± 0.01 | |||
| 1.3 ± 0.25* | 1.3 ± 0.31* | 1.5 ± 0.74* | 1.3 ± 0.21* | 1.4 ± 0.21* | 1.4 ± 0.76* | 0.7 ± 0.03 | |||
| 0.2% | 0.31 ± 0.11 | 0.30 ± 0.10 | 0.31 ± 0.08 | 0.30 ± 0.05 | 0.27 ± 0.03 | 0.25 ± 0.05 | 0.31 ± 0.06 | ||
| 0.03 ± 0.01 | 0.03 ± 0.01 | 0.05 ± 0.02 | 0.03 ± 0.01 | 0.02 ± 0.01 | 0.03 ± 0.02 | 0.01 ± 0.02 | |||
| 0.05 ± 0.01 | 0.01 ± 0.01 | 0.05 ± 0.01 | 0.02 ± 0.02 | 0.05 ± 0.03 | 0.05 ± 0.02 | 0.02 ± 0.01 | |||
| 0.08 ± 0.01 | 0.50 ± 0.01 | 0.52 ± 0.01 | 0.5 ± 0.02 | 0.07 ± 0.02 | 0.23 ± 0.02 | 0.28 ± 0.09 | |||
| 0.02 ± 0.01 | 0.05 ± 0.01 | 0.05 ± 0.01 | 0.03 ± 0.01 | 0.05 ± 0.02 | 0.05 ± 0.01 | 0.01 ± 0.02 |
Suspensions of LAB (107 CFU/mL) in MRS broth without sorbic acid were added into the wells with 48-h old biofilms pre-formed by pathogenic bacteria and incubation was continued for the next 24 h. ΔpH and ΔTTA were calculated as a difference between initial and final values. The Total Titratable Acidity (TTA) is expressed as mL of 0.1 M NaOH as required to achieve the final pH of 8.2
* denotes statistically significant difference with probiotic strain L. plantarum 8PA3 (p < 0.05)
The broth acidification rate in mixed cultures of novel LAB strains and pathogenic bacteria
| Glucose | Strains | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| ΔpH | 2% | 3.4 ± 0.35* | 3.2 ± 0.24* | 3.4 ± 0.31* | 3.6 ± 0.56* | 3.3 ± 0.23* | 3.2 ± 0.11* | 2.3 ± 0.15 | |
| 0.5 ± 0.27* | 0.5 ± 0.67* | 0.6 ± 0.35* | 0.4 ± 0.19* | 0.5 ± 0.5* | 0.8 ± 0.52* | −0.3 ± 0.29 | |||
| 3.0 ± 0.62 | 3.0 ± 0.50 | 3.1 ± 0.52 | 3.0 ± 0.62 | 3.1 ± 0.51 | 3.1 ± 0.62 | 2.9 ± 0.23 | |||
| 2.6 ± 0.66 | 2.6 ± 0.75 | 2.6 ± 0.72 | 2.6 ± 0.65 | 2.6 ± 0.64 | 2.6 ± 0.61 | 2.3 ± 0.68 | |||
| 3.6 ± 0.06* | 3.8 ± 0.31* | 3.7 ± 0.53* | 3.7 ± 0.52* | 3.7 ± 0.67* | 4.0 ± 0.25* | 2.9 ± 1.53 | |||
| 0.2% | 3.5 ± 0.34* | 2.0 ± 0.53* | 2.2 ± 0.46* | 1.8 ± 0.27* | 2.2 ± 0.38* | 2.2 ± 0.62* | 1.2 ± 0.25 | ||
| −0.3 ± 0.16 | − 0.3 ± 0.15 | −0.3 ± 0.02 | − 0.2 ± 0.01 | −0.3 ± 0.13 | − 0.2 ± 0.37 | −0.3 ± 0.11 | |||
| 1.2 ± 0.28 | 1.2 ± 0.38 | 1.3 ± 0.17 | 1.1 ± 0.33 | 1.3 ± 0.05 | 0.9 ± 0.16 | 1.2 ± 0.28 | |||
| 0.5 ± 0.69 | 0.3 ± 0.42 | 1.0 ± 0.56 | 0.6 ± 1.16 | 0.9 ± 0.15 | 0.3 ± 0.37 | 0.3 ± 0.97 | |||
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| ΔTTA | 2% | 2.2 ± 0.63* | 1.5 ± 0.43* | 1.7 ± 0.65* | 2.3 ± 0.87* | 1.8 ± 0.57* | 1.3 ± 0.23* | 0.1 ± 0.01 | |
| 0.9 ± 0.12* | 0.6 ± 0.09 | 0.8 ± 0.08* | 0.6 ± 0.34 | 0.7 ± 0.37* | 0.7 ± 0.36* | 0.1 ± 0.02 | |||
| 1.1 ± 0.23 | 1.3 ± 0.16 | 1.5 ± 0.31 | 0.8 ± 0.42 | 1.4 ± 0.48 | 1.1 ± 0.39 | 1.5 ± 0.15 | |||
| 1.3 ± 0.22* | 1.0 ± 0.11 | 1.1 ± 0.13 | 1.3 ± 0.61* | 1.9 ± 0.13* | 1.5 ± 0.35 | 0.8 ± 0.13 | |||
| 1.7 ± 0.41* | 1.5 ± 0.21 | 2.0 ± 0.56* | 1.7 ± 0.24* | 1.8 ± 0.28* | 2.0 ± 0.29* | 1.0 ± 0.08 | |||
| 0.2% | 0.31 ± 0.11 | 0.27 ± 0.10 | 0.30 ± 0.02 | 0.32 ± 0.05 | 0.27 ± 0.03 | 0.25 ± 0.05 | 0.31 ± 0.06 | ||
| 0.04 ± 0.02 | 0.04 ± 0.02 | 0.01 ± 0.01 | 0.01 ± 0.01 | 0.04 ± 0.02 | 0.04 ± 0.02 | 0.04 ± 0.02 | |||
| 0.00 ± 0.01 | 0.00 ± 0.01 | 0.00 ± 0.01 | 0.00 ± 0.01 | 0.00 ± 0.01 | 0.00 ± 0.01 | 0.05 ± 0.01 | |||
| 0.05 ± 0.01 | 0.00 ± 0.01 | 0.11 ± 0.01 | 0.05 ± 0.01 | 0.05 ± 0.01 | 0.00 ± 0.01 | 0.05 ± 0.01 | |||
| 0.31 ± 0.05 | 0.30 ± 0.05 | 0.31 ± 0.04 | 0.30 ± 0.05 | 0.31 ± 0.05 | 0.31 ± 0.05 | 0.29 ± 0.05 |
Mixed suspensions of LAB and pathogenic bacteria (107 CFU/mL each) in MRS broth without sorbic acid were grown for 48 h. ΔpH and ΔTTA were calculated as a difference between initial and final values. Total Titratable Acidity (TTA) is expressed as mL of 0.1 M NaOH needed to achieve the final pH of 8.2
* denotes statistically significant difference with probiotic strain L. plantarum 8PA3 (p < 0.05)
Fig. 3Antimicrobial activity of novel LAB strains against planktonic and biofilm embedded forms of pathogenic bacteria when growing in MRS with 10-fold reduced glucose content (0.2%). LAB suspensions in MRS broth (107 CFU/ml) were added to 48-h old biofilms of pathogenic bacteria. After 24 h CFUs of bacteria were calculated on differential media. Data are shown as medians with IQR. Asterisks denote statistically significant difference with monocultures of pathogenic bacteria (p < 0.05)
Fig. 4Repression of pathogenic bacteria by novel LAB in co-cultivation experiments in MRS with 10-fold reduced glucose content (0.2%). Suspensions of LAB and pathogenic bacteria (107 CFU/mL each) in MRS broth without sorbic acid were grown for 48-h and CFUs of bacteria were calculated on differential media. Data are shown as medians with IQR. Asterisks denote statistically significant difference with monocultures of pathogenic bacteria (p < 0.05)
Characterization of probiotic properties of novel LAB strains isolated from silage
| LAB species | Strain | Survival rate, % | Hydrophobicity | Auto-aggregation, % | ||
|---|---|---|---|---|---|---|
| % a | Grade b | 4 h | 24 h | |||
| AG1 | 6.0 ± 3.70 | 18.4 ± 2.40 | L | 26.8 ± 4.63 | 90.3 ± 7.83 | |
| AG8 | 13.1 ± 1.47 | 24.4 ± 2.00 | L | 26.0 ± 5.86 | 79.6 ± 8.98 | |
| AG9 | 11.4 ± 0.60 | 55.6 ± 1.71 | M | 35.6 ± 3.04 | 88.7 ± 5.28 | |
| AG10 | 26.0 ± 0.14 | 65.7 ± 7.52 | M | 21.7 ± 7.00 | 66.6 ± 7.44 | |
| AG15 | 25.9 ± 0.70 | 3.2 ± 0.42 | L | 25.1 ± 6.52 | 78.5 ± 7.26 | |
| AG16 | 3.5 ± 0.54 | 41.2 ± 5.06 | M | 26.4 ± 4.18 | 85.5 ± 5.40 | |
| 8PA3 | 8.2 ± 0.92 | 23.2 ± 1.03 | L | 23.1 ± 4.23 | 72.7 ± 8.35 | |
a Percentage of hydrophobicity
b Strains were classified as low (L) or medium (M) according to their hydrophobicity capacities according to [44]
Antibiotic resistance of newly isolated LAB strains from silage (diameters of inhibition zones, mm)
| Antibiotics | Amount per disc, μg | LAB strains | |||||
|---|---|---|---|---|---|---|---|
| AG1 | AG8 | AG9 | AG10 | AG15 | AG16 | ||
| Ampicillin | 10 | 26(S) | 18(S) | 20(S) | 19(S) | 20(S) | 17(S) |
| Amikacin | 30 | 12(R) | 16(I) | 9(R) | 10(R) | 3(R) | 8(R) |
| Chloramphenicol | 30 | 22(S) | 25(S) | 28(S) | 23(S) | 22(S) | 29(S) |
| Ciprofloxacin | 5 | 0(R) | 0(R) | 0(R) | 0(R) | 0(R) | 9(R) |
| Clindamycin | 2 | 16(S) | 15(S) | 33(S) | 18(S) | 28(S) | 24(S) |
| Erythromycin | 15 | 20(S) | 20(S) | 26(S) | 22(S) | 20(S) | 26(S) |
| Gentamicin | 10 | 10(R) | 11(R) | 10(R) | 9(R) | 0(R) | 13(S) |
| Kanamycin | 30 | 0(R) | 0(R) | 6(R) | 0(R) | 0(R) | 5(R) |
| Rifampicin | 5 | 20(S) | 26(S) | 20(S) | 20(S) | 13(R) | 30(S) |
| Streptomycin | 30 | 10(R) | 14(I) | 8(R) | 11(R) | 11(R) | 11(R) |
| Tetracycline | 30 | 20(S) | 20(S) | 20(S) | 21(S) | 19(S) | 25(S) |
| Vancomycin | 30 | 0(R) | 0(R) | 6(R) | 14(R) | 0(R) | 2(R) |
Inhibition zones (mm) (means ± SD of 3 trials) were interpreted as susceptible (S), intermediate (I), or resistant (R) according to [45]
Properties of fermented skimmed milk
| Strain | Protein, % | Whey protein, % | Lactose, % | Solids, % | pH | TTA. ml | WHCa, % | Syneresis, g water/100 g yoghurt | Dynamic viscosity, sec |
|---|---|---|---|---|---|---|---|---|---|
| AG1 | 4.1 ± 0.08 | 3.0 ± 0.11 | 4.5 ± 0.07 | 8.8 ± 0.11 | 3.7 ± 0.08 | 1.0 ± 0.01 | 36 ± 4.2 | 22 ± 2.9 | 6.6 ± 0.17 |
| AG8 | 4.2 ± 0.10 | 3.1 ± 0.08 | 4.5 ± 0.11 | 9.4 ± 0.14 | 3.7 ± 0.08 | 1.1 ± 0.02 | 37 ± 1.60 | 19 ± 1.5 | 7.1 ± 0.09 |
| AG9 | 4.2 ± 0.08 | 3.0 ± 0.11 | 4.5 ± 0.08 | 9.4 ± 0.20 | 3.7 ± 0.20 | 1.0 ± 0.02 | 35 ± 2.88 | 24 ± 3.5 | 7.8 ± 0.28 |
| AG10 | 4.1 ± 0.08 | 3.1 ± 0.08 | 4.6 ± 0.04 | 9.5 ± 0.17 | 3.6 ± 0.08 | 1.1 ± 0.02 | 36 ± 2.88 | 19 ± 4.2 | 7.1 ± 0.17 |
| AG15 | 4.1 ± 0.10 | 3.1 ± 0.06 | 4.4 ± 0.14 | 9.7 ± 0.07 | 3.9 ± 0.13 | 1.0 ± 0.02 | 37 ± 3.48 | 24 ± 3.1 | 6.0 ± 0.22 |
| AG16 | 4.2 ± 0.10 | 3.0 ± 0.06 | 4.5 ± 0.10 | 9.1 ± 0.09 | 3.9 ± 0.08 | 1.0 ± 0.01 | 34 ± 2.11 | 24 ± 2.1 | 6.6 ± 0.11 |
| Yogurt | 4.2 ± 0.22 | 3.1 ± 0.04 | 4.5 ± 0.11 | 11.1 ± 0.11 | 3.9 ± 0.21 | 0.9 ± 0.02 | 39 ± 3.48 | 23 ± 3.5 | 7.2 ± 0.17 |
| Milk | 4.2 ± 0.09 | – | 4.7 ± 0.08 | 8.7 ± 0.173 | 6.7 ± 0.10 | 0.2 ± 0.01 | – | – | – |
aWHC Water holding capacity